[1]
E. Michailidis, “Effect of translocation defective reverse transcriptase inhibitors on the activity of N348I, a connection subdomain drug resistant HIV-1 reverse transcriptase mutant”, Cell Mol Biol (Noisy-le-grand), vol. 58, no. 1, pp. 187–195, Dec. 2012.